Mahendra Deonarain

Mahendra Deonarain

Company: Antikor Biopharma

Job title: Chief Executive & Science Officer

Seminars:

Developing Antibody Fragment Drug Conjugates for Solid Tumors 2:00 pm

Fine-tuning our FDC discovery platform to discover antibody fragments and linker-payloads tailored for solid tumors Outlining the discovery of Antikor’s lead FDC program (ANT-045) and follow-up programs Reviewing the development of ANT-045 FDC in advanced models for tumor cure efficacy and safetyRead more

day: Scientific Program Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.